Peter Haahr

Peter Haahr is currently a Board Member at Leo Pharma. Peter has previously served as a Board Member at HC Andersen Capital, Symphogen, and NNIT. Peter has also been the Chief Financial Officer at Novo Holdings and a Member of the Advisory Board at Exhalation Technology Ltd.

Peter Haahr began their educational career at Stanford University, where they studied directors' consortiums. Peter then went on to study leadership at IMD and finance and accounting at Aarhus University.